Hypertension Clinical Trial
Official title:
Searching for Accomplices in the Transgression of Insulin Resistance in Prehypertension: Aldosterone?
The purposes of the study are to evaluate the relative contributions of insulin resistance and renin-angiotensin-aldosterone system to blood pressure (BP) in subjects with prehypertension. This is a cross-sectional study. Anthropometric and BP measurements will be performed in 50 prehypertensive subjects. The subjects will receive a 75-g oral glucose tolerance test and a postural stimulation test for the measurements of insulin resistance, plasma rennin concentration and aldosterone level. Log (ISI0,120), an insulin sensitivity index from the oral glucose tolerance test, will be calculated. Statistical analyses will be performed to compare the degree to which aldosterone and Log (ISI0,120) predicted systolic and diastolic BP in these prehypertensive subjects.
Background: Prehypertension, a new category of blood pressure (BP) classification introduced
by The Seven Report of the Joint National Commission (JNC-7) on High BP for individuals with
systolic BP in the range of 120-139 mmHg or diastolic BP between 80-89 mmHg, is a strong
predictor for the development of hypertension. Insulin resistance (IR) is reported to be
associated with prehypertension. Activation of the renin-angiotensin-aldosterone (RAA)
system is a major player in IR and elevation of high BP.
Aim: The purposes of the study are to evaluate the interactions of IR-RAA and their relative
contributions to BP in subjects with prehypertension.
Design: This is a cross-sectional study. Methods: Anthropometric and BP measurements will be
performed in 50 prehypertensive subjects. The subjects will receive a 75-g oral glucose
tolerance test (OGTT) and a postural stimulation test for the measurements of IR, plasma
rennin concentration (PRC) and aldosterone level. The study participants will be divided
into three subgroups by tertiles of Log (ISI0,120), an insulin sensitivity index from the
OGTT. Analysis of variance (ANOVA) will be applied to compare the differences in clinical
characteristics among the three groups. Univariate analyses of general linear models will be
used to compare the differences in PRC, aldosterone, and aldosterone/rennin ratio (ARR) in
postural stimulation tests among the three subgroups, showing effects of confounding
variables including age, sex, BMI and physical inactivity scores. Repeated-measures ANOVA
will be used to assess the differences in post-challenge PRC, aldosterone, and ARR responses
in the OGTT with or without adjustments of the above covariates. Pearson and partial
correlation procedures will be used to test the correlations of PRC, aldosterone, ARR with
insulin sensitivity and BP. Multiple linear regression models will be used in an attempt to
compare the degree to which aldosterone (or ARR) and Log (ISI0,120) predicted systolic and
diastolic BP in these prehypertensive subjects.
Expected results and contributions: We hope the study can explore the contribution of the
IR-RAA interactions to BP in subjects with prehypertension.
;
Observational Model: Cohort, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |